Dermatitis, Eczematous Completed Phase 2 Trials for Prednicarbate (DB01130)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01020994Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected EczemaTreatment